Novanta Inc. (NASDAQ:NOVT – Free Report) – Analysts at William Blair lowered their Q1 2025 earnings estimates for Novanta in a research note issued on Tuesday, February 25th. William Blair analyst B. Drab now forecasts that the technology company will post earnings of $0.68 per share for the quarter, down from their previous forecast of $0.78. The consensus estimate for Novanta’s current full-year earnings is $3.03 per share. William Blair also issued estimates for Novanta’s Q2 2025 earnings at $0.76 EPS, Q3 2025 earnings at $0.96 EPS, Q4 2025 earnings at $1.08 EPS, FY2025 earnings at $3.48 EPS and FY2026 earnings at $4.15 EPS.
Novanta (NASDAQ:NOVT – Get Free Report) last announced its earnings results on Tuesday, February 25th. The technology company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.05. The company had revenue of $238.10 million during the quarter, compared to the consensus estimate of $240.29 million. Novanta had a return on equity of 15.20% and a net margin of 6.52%. The firm’s revenue for the quarter was up 12.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 earnings per share.
Get Our Latest Analysis on NOVT
Novanta Price Performance
NASDAQ NOVT opened at $144.64 on Thursday. The stock has a 50-day moving average of $148.83 and a 200 day moving average of $164.56. Novanta has a one year low of $137.91 and a one year high of $187.12. The company has a market capitalization of $5.20 billion, a price-to-earnings ratio of 86.61 and a beta of 1.28. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79.
Hedge Funds Weigh In On Novanta
A number of hedge funds have recently made changes to their positions in NOVT. Vanguard Group Inc. lifted its holdings in Novanta by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 4,123,828 shares of the technology company’s stock worth $629,997,000 after purchasing an additional 62,585 shares in the last quarter. Conestoga Capital Advisors LLC lifted its stake in Novanta by 1.6% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,350,651 shares of the technology company’s stock worth $241,658,000 after purchasing an additional 20,825 shares in the last quarter. State Street Corp boosted its holdings in shares of Novanta by 2.0% during the 3rd quarter. State Street Corp now owns 1,298,419 shares of the technology company’s stock valued at $232,313,000 after purchasing an additional 24,929 shares during the last quarter. Alliancebernstein L.P. grew its holdings in Novanta by 6.2% during the 4th quarter. Alliancebernstein L.P. now owns 1,004,879 shares of the technology company’s stock valued at $153,515,000 after buying an additional 58,864 shares in the last quarter. Finally, William Blair Investment Management LLC increased its stake in Novanta by 1.2% in the 4th quarter. William Blair Investment Management LLC now owns 975,841 shares of the technology company’s stock worth $149,079,000 after acquiring an additional 11,361 shares during the last quarter. Institutional investors own 98.35% of the company’s stock.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading
- Five stocks we like better than Novanta
- How to Read Stock Charts for Beginners
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What does consumer price index measure?
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to trade penny stocks: A step-by-step guide
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.